For being a successful vaccine business, a part of our strategies is creating partnerships with individuals, academia, charities, small biotech as well as large pharmaceutical companies. Working with external organizations within our area will help us in scientific and clinical decision-making while focusing on patient care. We believe that innovative prophylactic and therapeutic vaccines are coming as a result of successful human R&D resources and business development collaborations.
Immunor typically would like to develop project partnerships with single-purpose companies. Still, the current partners are open for inclusion of additional partners to ensure a reliable and fast development path. Further information, please fill out the form below, we will get back to you.
For now, Immunor has already created the initial project collaborations for some of its vaccine projects.